These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4782297)

  • 21. Possible rationale for procaine (Gerovital H3) therapy in geriatrics: inhibition of monoamine oxidase.
    MacFarlane MD
    J Am Geriatr Soc; 1973 Sep; 21(9):414-8. PubMed ID: 4737639
    [No Abstract]   [Full Text] [Related]  

  • 22. Gerovital-H3--a review of the literature.
    Jarvik LF; Milne JF
    Psychopharmacol Bull; 1975 Oct; 11(4):51-3. PubMed ID: 717
    [No Abstract]   [Full Text] [Related]  

  • 23. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Considerations on the therapeutic management of mixed psychoses and of depressive manifestations symptomatic of schizophrenia].
    Scala A
    Osp Psichiatr; 1967; 35(4):501-34. PubMed ID: 5607254
    [No Abstract]   [Full Text] [Related]  

  • 25. Phenelzine as a possible treatment for depression in schizophrenic patients.
    Melamed Y; Karniel E; Szor H
    Isr J Psychiatry Relat Sci; 1996; 33(3):211-2. PubMed ID: 9009521
    [No Abstract]   [Full Text] [Related]  

  • 26. Monoamine oxidase inhibitors.
    Masters AB
    Can Med Assoc J; 1971 Dec; 105(12):1281. PubMed ID: 5150330
    [No Abstract]   [Full Text] [Related]  

  • 27. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical study of a new antidepressant inhibitor of monoamine oxidase: R.C. 41.10].
    Lafon R; Minvielle J; Chapel A; Chabanier J
    Therapie; 1966; 21(6):1405-11. PubMed ID: 6002648
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moclobemide treatment of clozapine-induced hypersalivation: pilot open study.
    Kreinin A; Miodownik C; Libov I; Shestakova D; Lerner V
    Clin Neuropharmacol; 2009; 32(3):151-3. PubMed ID: 19483481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoamine oxidase inhibitors in the control of migraine.
    Anthony M; Lance JW
    Proc Aust Assoc Neurol; 1970; 7():45-7. PubMed ID: 4937098
    [No Abstract]   [Full Text] [Related]  

  • 32. MAO inhibition and antidepressant activity.
    Feldstein A; Hoagland H; Rivera Oktem M; Freeman H
    Int J Neuropsychiatry; 1965 Aug; 1(4):384-7. PubMed ID: 5324597
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical studies with MO-1255, a new monoamine oxidase inhibitor antidepressant.
    Ban TA; St-Jean A; Lehmann HE
    Curr Ther Res Clin Exp; 1966 Dec; 8(12):614-6. PubMed ID: 4962732
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical pharmacology of MAO inhibitors: safety and future.
    Yamada M; Yasuhara H
    Neurotoxicology; 2004 Jan; 25(1-2):215-21. PubMed ID: 14697896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Notes on the use of monoamine oxidase inhibitor drugs].
    Gayral L
    Therapie; 1966; 21(5):1175-81. PubMed ID: 5976766
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of monoaminoxidase inhibitor vetrazine in the treatment of acute pancreatitis].
    Akzhigitov GN
    Ter Arkh; 1968 Oct; 40(10):82-4. PubMed ID: 5741368
    [No Abstract]   [Full Text] [Related]  

  • 37. [Monoamine oxidase inhibitors in treatment of bulbar ulcer: 10 treated cases].
    Marquier A
    Arch Fr Mal App Dig; 1968 Jun; 57(4):511-2. PubMed ID: 5741156
    [No Abstract]   [Full Text] [Related]  

  • 38. [Accidents due to local and regional anesthesia in patients treated with monoamine oxidase inhibitors].
    Delaire J; Horeau J; Billet J; Dubigeon M
    Rev Stomatol Chir Maxillofac; 1967 Dec; 68(8):653-8. PubMed ID: 5242967
    [No Abstract]   [Full Text] [Related]  

  • 39. Rapid conversion from one monoamine oxidase inhibitor to another.
    Szuba MP; Hornig-Rohan M; Amsterdam JD
    J Clin Psychiatry; 1997 Jul; 58(7):307-10. PubMed ID: 9269251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A perspective on adjunctive therapy for Parkinson disease with monoamine oxidase-B inhibition.
    LeWitt PA
    Clin Neuropharmacol; 2007; 30(5):305-7. PubMed ID: 17909310
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.